Author - Kevin Costa

Home » Archives for Kevin Costa » Page 2

CRISPR is stuck, and this company can fix it

CRISPR may be the defining technology of this young century, but its arrival is also a kind of déjà vu on scale of the Human Genome Project. Back in 2003, we celebrated the $3 billion sequencing of a single human...

Five must-dos for potential biotech start-ups

Thinking about a biotech start-up? James Currier, a four-time VC-backed CEO and manager of NFX’s biotech fund, shares his valuable advice. This article is brought to you by NFX, a Silicon Valley based venture firm that...

What — and who — is synthetic biology?

If you ask three synthetic biologists, “What is synthetic biology?”, you are likely to get four, maybe five or more answers. So what is it? Simply put, synthetic biology is an engineering approach to biology...